# Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

> **NCT01898130** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 27 (actual)

## Conditions studied

- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** bevacizumab
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT01898130
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-27
- **Primary completion:** 2017-03-23
- **Final completion:** 2018-09-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898130, "Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01898130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*